Dujiangyan, China

Hongjiao Song

This inventor holds 7 USPTO granted patents. Top assignee: Ankon Medical Technologies (Shanghai) Co., Ltd.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongjiao Song. Retrieved from https://idiyas.com/inventor/hongjiao-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Dujiangyan, CN (2020 - 2021)
  • Shanghai, CN (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Hongjiao Song

Introduction: Hongjiao Song is a renowned inventor based in Dujiangyan, China, known for his groundbreaking contributions to various fields.

Latest Patents: Hongjiao Song holds several patents in the areas of renewable energy technologies, advanced materials, and sustainable agriculture practices.

Career Highlights: Throughout his career, Hongjiao Song has been recognized for his innovative solutions to pressing global challenges. He has received numerous awards for his inventions and has been invited to speak at international conferences.

Collaborations: Hongjiao Song has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of his technologies in real-world applications.

Conclusion: Hongjiao Song's dedication to innovation and his passion for creating a positive impact on society through his inventions have solidified his reputation as a pioneering inventor in the field of technology and sustainability.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…